FDABridge
← Balik sa blog
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

FDA Stories #016 β€” An Egyptian Dates Exporter's Prior Notice Had the Wrong FDA Registration Number

The product claimed to 'boost energy and support immune function.' Those are structure/function claims. The product needed a Supplement Facts panel, not a Nutrition Facts panel.

Koponan ng FDABridgeβ€’Ene 1, 2026β€’3 min na mabasa

A matcha company in Uji, Kyoto, produced a premium ceremonial-grade matcha powder that they sold in Japan as a traditional tea. When they expanded to the US, their American distributor suggested adding health claims to the marketing: 'Boosts energy naturally,' 'Supports immune function,' 'Rich in antioxidants for cellular health.'

The product was labeled as a food with a Nutrition Facts panel. The marketing materials β€” on the website, on Amazon, and on shelf talkers β€” contained structure/function claims.

The classification problem

Under US law, a product that makes structure/function claims β€” claims about how a substance affects the structure or function of the body β€” is either a dietary supplement (if it contains a dietary ingredient and is intended for ingestion) or a drug (if the claims go further into disease treatment). A conventional food cannot make structure/function claims without triggering reclassification. 'Boosts energy' and 'supports immune function' are structure/function claims that pushed the matcha from the food category into the dietary supplement category.

As a dietary supplement, the product needed a Supplement Facts panel (not Nutrition Facts), the required disclaimer ('This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease'), a structure/function claim notification filed with the FDA within 30 days of first marketing, and facility registration under the dietary supplement CGMP requirements of 21 CFR Part 111.

What we did

The company had two paths. They could remove all structure/function claims and sell the matcha as a conventional food β€” which would require only the standard food facility registration and a Nutrition Facts panel. Or they could keep the claims and comply with dietary supplement regulations. They chose to sell the matcha as a conventional food in retail stores (no health claims) and as a dietary supplement through their e-commerce channel (with compliant claims and labeling). Two SKUs. Two labels. Two regulatory pathways from the same facility.

If your product is a tea, powder, extract, or botanical and you want to make health-related claims in the US β€” you are almost certainly selling a dietary supplement, not a food. The labeling, registration, and compliance requirements are different. Get it right before you launch. fdabridge.com/contact.

Kailangan mo ng tulong sa susunod?

Kailangan ng tulong sa pagpili ng serbisyo?

Ihambing ang mga serbisyo at piliin ang tamang filing path para sa iyong produkto.

Mas marami pang mabasa

Mga kaugnay na artikulo

Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Mga simbolo sa paglalaman ng medikal na aparato: Ano ang Dapat Malaman ng mga Pang-aalaga sa Kanlurang Bansa Para sa pagpasok sa Mercado ng US

Abr 28, 2026

Ang pagpapalagay ng medikal na aparato sa Estados Unidos ay nangangailangan ng mga tiyak na simbolo para sa tamang komunikasyon. Dapat maunawaan ng mga dayuhang tagagawa ang mga pamantayan ng simbolo na tinatanggap ng FDA bago mag-export ng mga aparato sa merkado ng Amerika.

Magbasa pa β†’
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Pagrehistro ng Medikal na Disposisyon para sa mga dayuhang tagagawa: Isang Gawain sa US Regulatory System

Mar 26, 2026

Ang mga tagagawa ng mga medikal na aparato ng dayuhan ay dapat magrehistro ng kanilang mga establisimento, maglista ng kanilang mga aparato, at depende sa klase ng aparato makakuha ng pag-aalis o pahintulot ng FDA bago i-distribute sa Estados Unidos.

Magbasa pa β†’
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Sampong Tanong Dapat Itanong Bago Mag-upa ng isang Konsultor ng FDA

May 24, 2026

Ang pagpili ng isang tagapagbigay ng serbisyo sa pagsunod sa FDA ay isang resulta ng desisyon. Ang sampung tanong na ito ay tumutulong sa mga dayuhang tagagawa na ihiwalayin ang mga may kakayahan na konsultante mula sa mga magtataguyod ng mga problema na hindi nila maiiwasan.

Magbasa pa β†’